Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SPNE

SeaSpine (SPNE) Stock Price, News & Analysis

SeaSpine logo

About SeaSpine Stock (NASDAQ:SPNE)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
$7.03
$9.54
52-Week Range
N/A
Volume
1.16 million shs
Average Volume
822,700 shs
Market Capitalization
$354.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

As of January 4, 2023, SeaSpine Holdings Corporation was acquired by Orthofix Medical Inc. SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

Remove Ads
Receive SPNE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SeaSpine and its competitors with MarketBeat's FREE daily newsletter.

SPNE Stock News Headlines

[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.
Spine Biologics Market Size to Achieve USD 6.95 Bn by 2033
Q2 2024 Orthofix Medical Inc Earnings Call
See More Headlines

SPNE Stock Analysis - Frequently Asked Questions

SeaSpine Holdings Co. (NASDAQ:SPNE) announced its quarterly earnings results on Thursday, October, 28th. The medical equipment provider reported ($0.48) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by $0.17. The firm's revenue for the quarter was up 7.5% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that SeaSpine investors own include AbbVie (ABBV), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Amarin (AMRN), Alphatec (ATEC), Meta Platforms (META) and uniQure (QURE).

Company Calendar

Last Earnings
10/28/2021
Today
4/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SPNE
Fax
N/A
Employees
523
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-54,350,000.00
Pretax Margin
-28.83%

Debt

Sales & Book Value

Annual Sales
$191.45 million
Price / Cash Flow
N/A
Book Value
$8.57 per share
Price / Book
1.11

Miscellaneous

Free Float
33,736,000
Market Cap
$354.92 million
Optionable
Optionable
Beta
1.31

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:SPNE) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners